Summit Global Investments’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,500	Closed	-$761K	–	307
2018 Q3	$761K	Buy	26,500 +2,600	+11%	+$74.7K	0.1%	183
2018 Q2	$652K	Buy	+23,900	New	+$652K	0.1%	194